The Current Ratio of Jounce Therapeutics Inc (JNCE) is
8.37.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2022-12-31 |
8.37
|
| 2021-12-31 |
10.10
|
| 2020-12-31 |
10.95
|
| 2019-12-31 |
12.06
|
| 2018-12-31 |
2.93
|
| 2017-12-31 |
4.08
|
| 2016-12-31 |
1.67
|
| 2015-12-31 |
6.82
|
| 2014-12-31 |
1.16
|
| 2013-12-31 |
1.57
|
| Ticker |
Name |
Value |
|
NLTX
|
Neoleukin Therapeutics Inc
|
8.93
|
|
SYRS
|
Syros Pharmaceuticals Inc
|
3.95
|
|
XOMA
|
XOMA Royalty Corporation
|
3.37
|
|
APLT
|
Applied Therapeutics Inc
|
3.11
|
|
CNTG
|
Centogene NV
|
1.02
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
12.32
|
|
ANAB
|
AnaptysBio, Inc.
|
5.61
|
|
BCYC
|
Bicycle Therapeutics PLC
|
11.98
|
|
CTMX
|
CytomX Therapeutics, Inc.
|
3.09
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
2.42
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
ACET
|
ADICET Bio, Inc.
|
7.47
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
SESN
|
Sesen Bio Inc
|
17.77
|
|
SMMT
|
Summit Therapeutics Inc.
|
9.87
|
|
SQZ
|
SQZ Biotechnologies Co
|
3.12
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
HARP
|
Harpoon Therapeutics Inc
|
1.04
|
|
RAPT
|
RAPT Therapeutics, Inc
|
4.90
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
ALDX
|
Aldeyra Therapeutics Inc
|
2.58
|
|
AUTL
|
Autolus Therapeutics PLC
|
5.94
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
AGEN
|
Agenus Inc
|
0.41
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
11.34
|
|
SELB
|
Selecta Biosciences Inc
|
5.91
|
|
SPRO
|
Spero Therapeutics, Inc.
|
7.59
|
|
GERN
|
Geron Corporation
|
4.66
|
|
INZY
|
Inozyme Pharma Inc
|
3.56
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
XBIT
|
XBiotech Inc
|
16.01
|
|
AVRO
|
AVROBIO Inc
|
15.78
|
|
DTIL
|
Precision Biosciences, Inc
|
13.32
|
|
ETNB
|
89bio Inc
|
13.19
|